Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced as a new
treatment for patients with peritoneal metastases in November, 2011. Reports of its …

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …

Background The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to
cytoreductive surgery has been associated with encouraging survival results in some …

METHODS This guideline is based on the previous colon cancer parameter published in
2017. 10 Compared with 2017, this guideline has 11 new, 10 updated, and 2 excluded …

Background Patients with peritoneal metastatic colorectal cancer have reduced overall
survival compared with patients with metastatic colorectal cancer without peritoneal …

Background Diagnosis and treatment of colorectal peritoneal metastases at an early stage,
before the onset of signs, could improve patient survival. We aimed to compare the survival …

Purpose Peritoneal carcinomatosis (PC) from colorectal cancer traditionally is considered a
terminal condition. Approaches that combine cytoreductive surgery (CRS) and perioperative …

Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …